In a report released today, Serge Belanger from Needham maintained a Buy rating on Aerie Pharma (AERI – Research Report), with a price target of $14.00. The company's shares closed last Wednesday at $8.61. According to TipRanks.com, Belanger is a 4-star analyst with an average return of 6.3% and a 47.1% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Clarus Therapeutics Holdings, Amphastar Pharmaceuticals, and Collegium Pharmaceutical. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Aerie Pharma with a $18.20 average price target. See Insiders’ Hot Stocks on TipRanks >> Aerie Pharma's market cap is currently $378.
https://www.tipranks.com/news/blurbs/needham-maintains-a-buy-rating-on-aerie-pharma-aeri-2?utm_source=advfn.com&utm_medium=referral